LIGHT/TNFSF14 as a New Biomarker of Bone Disease in Multiple Myeloma Patients Experiencing Therapeutic Regimens

We have previously shown that through the production of high LIGHT levels, immune cells contribute to both osteoclastogenesis and bone destruction in Multiple Myeloma (MM)-related bone disease. With the aim of further exploring the mechanisms underlying the development of MM-related bone disease, he...

Descripción completa

Detalles Bibliográficos
Autores principales: Brunetti, Giacomina, Rizzi, Rita, Storlino, Giuseppina, Bortolotti, Sara, Colaianni, Graziana, Sanesi, Lorenzo, Lippo, Luciana, Faienza, Maria Felicia, Mestice, Anna, Curci, Paola, Specchia, Giorgina, Grano, Maria, Colucci, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206078/
https://www.ncbi.nlm.nih.gov/pubmed/30405638
http://dx.doi.org/10.3389/fimmu.2018.02459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206078/
https://www.ncbi.nlm.nih.gov/pubmed/30405638
http://dx.doi.org/10.3389/fimmu.2018.02459

Ejemplares similares